Neuroprotective Effect of Omega-3 Polyunsaturated Fatty Acids in the 6-OHDA Model of Parkinson’s Disease Is Mediated by a Reduction of Inducible Nitric Oxide Synthase
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Parkinson's disease (PD) is characterized by deterioration of the nigrostriatal system and associated with chronic neuroinflammation. Glial activation has been associated with regulating the survival of dopaminergic neurons and is thought to contribute to PD through the release of proinflammatory and neurotoxic factors, such as reactive nitric oxide (NO) that triggers or exacerbates neurodegeneration in PD. Polyunsaturated fatty acids (PUFAs) exert protective effects, including antiinflammatory, antiapoptotic, and antioxidant activity, and may be promising for delaying or preventing PD by attenuating neuroinflammation and preserving dopaminergic neurons. The present study investigated the effects of fish oil supplementation that was rich in PUFAs on dopaminergic neuron loss, the density of inducible nitric oxide synthase (iNOS)-immunoreactive cells, and microglia and astrocyte reactivity in the substantia nigra pars compacta (SNpc) and striatal dopaminergic fibers. METHODS: The animals were supplemented with fish oil for 50 days and subjected to unilateral intrastriatal 6-hydroxydopamine (6-OHDA)-induced lesions as a model of PD. RESULTS: Fish oil mitigated the loss of SNpc neurons and nerve terminals in the striatum that was caused by 6-OHDA. This protective effect was associated with reductions of the density of iNOS-immunoreactive cells and microglia and astrocyte reactivity. DISCUSSION: These results suggest that the antioxidant and antiinflammatory properties of fish oil supplementation are closely related to a decrease in dopaminergic damage that is caused by the 6-OHDA model of PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings are supported by experimental evidence that ω3-PUFAs reduce NOS activity and increase BDNF levels in the CNS [459,460].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [460]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1505s · Cited by 2,525
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Kim, W.-G., Mohney, R. P., Wilson, B., Jeohn, G.-H., Liu, B., & Hong, J.-S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06309.2000 · Cited by 878
Parkinson disease: from pathology to molecular disease mechanisms
Dexter, D. T., & Jenner, P. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.018 · Cited by 707
Joseph, J. D., & Ackman, R. G. (1992) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/75.3.488 · Cited by 379
Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease
Tadaiesky, M. T., Dombrowski, P. A., Figueiredo, C. P., Cargnin-Ferreira, E., Da Cunha, C., & Takahashi, R. N. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.035 · Cited by 343 · cited 1×
“…of administration of 6-OHDA were considered in an attempt to cause lesions of Nutritional Neuroscience 2018 VOL. 21 NO. 5 347 mild intensity.14,17 Tadaiesky et al. (2008) evaluated the effects of striatal 6-OHDA injections on locomotor activity in rats in the open-field test and found that…”
BackgroundContributions of central and systemic inflammation to the pathophysiology of Parkinson's disease
Collins, L. M., Toulouse, A., Connor, T. J., & Nolan, Y. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.028 · Cited by 306
Neuroinflammatory processes in Parkinson's disease
Hirsch, E. C., Hunot, S., & Hartmann, A. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.10.013 · Cited by 296
Cited by
Layé, S., Nadjar, A., Joffre, C., & Bazinet, R. P. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014092 · Cited by 420
“…2014; Tremoleda et al., 2016; Xu et al., 2016), Parkinson’s disease (Muntane et al., 2010; Ji et al., 2012; Tian et al., 2015; Delattre et al., 2017; Mori et al., 2017), AD (Lynch et al., 2007; Hopperton et al., 2016; Serini and Calviello, 2016;Wen et al., 2016), systemic inflammation (Delpech et…”
BackgroundThe Role of Lipids in Parkinson’s Disease
Xicoy, H., Wieringa, B., & Martens, G. J. M. (2019) · Cells · doi:10.3390/cells8010027 · Cited by 250
“Additionally, pretreatment of rats with fish oil (which is rich in omega-3 PUFA) for 25 days before 6-OHDA treatment mitigates the loss of substantia nigra (SN) DA neurons [83].”
BackgroundMohd Sairazi, N. S., & Sirajudeen, K. N. S. (2020) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2020/6565396 · Cited by 237
Rahman, M. H., Bajgai, J., Fadriquela, A., Sharma, S., Trinh, T. T., Akter, R., Jeong, Y. J., Goh, S. H., Kim, C.-S., & Lee, K.-J. (2021) · Molecules · doi:10.3390/molecules26175327 · Cited by 182
Docosahexaenoic and Arachidonic Acids as Neuroprotective Nutrients throughout the Life Cycle
Sambra, V., Echeverría, F., Valenzuela, A., Chouinard‐Watkins, R., & Valenzuela, R. (2021) · Nutrients · doi:10.3390/nu13030986 · Cited by 175
Metadata
- Authors
- Mori, M. A., Delattre, A. M., Carabelli, B., Pudell, C., Bortolanza, M., Staziaki, P. V., Visentainer, J. V., Montanher, P. F., Del Bel, E. A., & Ferraz, A. C.
- Affiliations
- Universidade Federal do Paraná (BR)
- Laboratório de Neurofisiologia, Departamento de Fisiologia, Universidade Federal do Paraná, 81531-990 Curitiba, PR, Brazil
- Universidade de São Paulo (BR)
- Laboratório de Química de Alimentos, Departamento de Química, Universidade Estadual de Maringá, Maringá, PR, Brazil
- Universidade Estadual de Maringá (BR)
- Departamento de Morfologia, Fisiologia e Patologia, Escola de Odontologia de Ribeirão Preto (FORP), Universidade de São Paulo, Av. Café s/n, 14040-904 Ribeirão Preto, SP, Brazil
- Corresponding author
- Ferraz, Anete Curte
- ORCID
- Venue
- Nutritional Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2017-02-21
- Volume
- 21
- Issue
- 5
- Pages
- 341-351
- ISSN
- 1028-415X (ISSN-L)
- 1476-8305
- OpenAlex
- W2591226798
- Cited by
- 89
- References
- 34
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 7 · 2023: 18 · 2022: 11 · 2021: 12 · 2020: 11 · 2019: 9 · 2018: 5 · 2017: 3
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nutritional Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- CNPq (552226/2011-4)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Parkinson's disease, omega-3 polyunsaturated fatty acids, fish oil supplementation, inducible nitric oxide synthase, 6-hydroxydopamine, neuroinflammation, dopaminergic neuron loss, substantia nigra pars compacta, striatum, microglial activation, astrocyte activation, neuroprotection, neurodegeneration
- MeSH terms
- Animals, Anti-Inflammatory Agents, Antioxidants, Astrocytes, Corpus Striatum, Disease Models, Animal, Dopamine, Fish Oils, Male, Nerve Degeneration, Nitric Oxide, Parkinson Disease, Fatty Acids, Omega-3, Oxidopamine, Rats, Wistar, Microglia, Neuroprotective Agents, Rats, Nitric Oxide Synthase Type II, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroprotective Effect of Omega-3 Polyunsaturated Fatty Acids in the 6-OHDA Model of Parkinson’s Disease Is Mediated by a Reduction of Inducible Nitric Oxide Synthase. https://app.cochat.ai/papers/10.1080/1028415x.2017.1290928
- The paper
- Mori, M. A., Delattre, A. M., Carabelli, B., Pudell, C., Bortolanza, M., Staziaki, P. V., Visentainer, J. V., Montanher, P. F., Del Bel, E. A., & Ferraz, A. C. (2018). Neuroprotective Effect of Omega-3 Polyunsaturated Fatty Acids in the 6-OHDA Model of Parkinson’s Disease Is Mediated by a Reduction of Inducible Nitric Oxide Synthase. Nutritional Neuroscience. https://doi.org/10.1080/1028415x.2017.1290928
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.